About the Wilms Tumor Session
Wilms tumor, also known as nephroblastoma, primarily affects the kidneys but can occasionally metastasize to the eyes, specifically to the retina. This occurrence is extremely rare but poses significant diagnostic challenges when it does happen. In ophthalmology, Wilms tumor typically presents as leukocoria, a white reflection from the retina resembling a cat's eye. This symptom is crucial for early detection and prompt treatment, which is essential due to the aggressive nature of the tumor. Ophthalmologists play a critical role in diagnosing ocular manifestations of Wilms tumor through detailed eye examinations, which may include indirect ophthalmoscopy and imaging techniques such as ultrasound or MRI. Collaborative efforts between ophthalmologists and pediatric oncologists are essential for comprehensive management and improving outcomes in patients with ocular involvement of Wilms tumor.
Topics Covered in Wilms Tumor
WAGR Syndrome
Congenital Aniridia
PAX6 & WT1 Deletions
Renal Ultrasound Surveillance
Orbital Metastasis
Leukocoria Differential Diagnosis
Related Scientific Sessions at IOC 2027
Why Attend the Wilms Tumor Conference 2027
Earn CPD Credit
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Present Your Research
Oral and poster slots for original Wilms Tumor work, reviewed by the scientific committee.
Network Globally
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Publish & Get Indexed
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Learn from Keynotes
Plenary lectures from leading voices shaping Wilms Tumor research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IOC 2027 for the Wilms Tumor track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Wilms Tumor Conference 2027 — FAQs
What is the Wilms Tumor track at IOC 2027?
The Wilms Tumor track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Wilms Tumor. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Wilms Tumor sessions?
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Wilms Tumor are all welcome — whether presenting or attending.
Can I present my research in the Wilms Tumor track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Wilms Tumor sessions?
Yes. IOC 2027 is a hybrid conference — attend the Wilms Tumor track in person in Singapore or join live online, with on-demand access afterward.
Join the IOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.